Listeria monocytogenes-derived listeriolysin O has pathogen-associated molecular pattern-like properties independent of its hemolytic ability

Clinical and Vaccine Immunology

Volumn 20, Issue 1, 2013, Pages 77-84

  Wallecha, Anu ^a   Wood, Laurence ^b,c   Pan, Zhen Kun ^b   Maciag, Paulo C ^b   Shahabi, Vafa ^a   Paterson, Yvonne ^b  

^a ADVAXIS INC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; LISTERIOLYSIN O; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROTEIN E7; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; GENE EXPRESSION; HEMOLYSIS; HUMAN PAPILLOMAVIRUS TYPE 16; LISTERIA MONOCYTOGENES; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; TUMOR REGRESSION; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-PRESENTING CELLS; BACTERIAL TOXINS; CANCER VACCINES; CYTOKINES; DENDRITIC CELLS; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; IMMUNOTHERAPY; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED C57BL; PAPILLOMAVIRUS E7 PROTEINS;

EID: 84872258754     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00488-12     Document Type: Article

References (37)

1. Tweten RK. 2005. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 73:6199-6209. (Pubitemid 41368781)
2. Cossart P, Vicente MF, Mengaud J, Baquero F, Perez-Diaz JC, Berche P. 1989. Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect. Immun. 57:3629-3636. (Pubitemid 19259901)
3. Marquis H, Bouwer HG, Hinrichs DJ, Portnoy DA. 1993. Intracytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants. Infect. Immun. 61:3756-3760. (Pubitemid 23260047)
4. Portnoy DA, Jacks PS, Hinrichs DJ. 1988. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J. Exp. Med. 167:1459-1471.
5. Rose F, Zeller SA, Chakraborty T, Domann E, Machleidt T, Kronke M, Seeger W, Grimminger F, Sibelius U. 2001. Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factors. Infect. Immun. 69:897-905. (Pubitemid 32109554)
6. Dramsi S, Cossart P. 2003. Listeriolysin O-mediated calcium influx potentiates entry of Listeria monocytogenes into the human Hep-2 epithelial cell line. Infect. Immun. 71:3614-3618. (Pubitemid 36637592)
7. Hamon MA, Batsche E, Regnault B, Tham TN, Seveau S, Muchardt C, Cossart P. 2007. Histone modifications induced by a family of bacterial toxins. Proc. Natl. Acad. Sci. U. S. A. 104:13467-13472. (Pubitemid 47293968)
8. Hussain SF, Paterson Y. 2004. CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector. J. Immunother. 27:339-346. (Pubitemid 39121922)
9. Nitcheu-Tefit J, Dai MS, Critchley-Thorne RJ, Ramirez-Jimenez F, Xu M, Conchon S, Ferry N, Stauss HJ, Vassaux G. 2007. Listeriolysin O expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo. J. Immunol. 179:1532-1541.
10. Carrero JA, Calderon B, Unanue ER. 2004. Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule. J. Immunol. 172:4866-4874. (Pubitemid 38456410)
11. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. 2004. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296. (Pubitemid 39061110)
12. Lamikanra A, Pan ZK, Isaacs SN, Wu TC, Paterson Y. 2001. Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site. J. Virol. 75:9654-9664. (Pubitemid 32900100)
13. Peng X, Treml J, Paterson Y. 2007. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy. Cancer Immunol. Immunother. 56:797-806. (Pubitemid 46723587)
14. Singh R, Dominiecki ME, Jaffee EM, Paterson Y. 2005. Fusion to listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse. J. Immunol. 175:3663-3673. (Pubitemid 41292026)
15. Darji A, Chakraborty T, Wehland J, Weiss S. 1995. Listeriolysin generates a route for the presentation of exogenous antigens by major histocompatibility complex class I. Eur. J. Immunol. 25:2967-2971.
16. Neeson P, Pan ZK, Paterson Y. 2008. Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma. Cancer Immunol. Immunother. 57:493-505. (Pubitemid 351170533)
17. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y. 2001. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J. Immunol. 167:6471-6479. (Pubitemid 33081581)
18. Schnupf P, Portnoy DA, Decatur AL. 2006. Phosphorylation, ubiquitination and degradation of listeriolysin O in mammalian cells: role of the PEST-like sequence. Cell. Microbiol. 8:353-364. (Pubitemid 43356056)
19. Sewell DA, Douven D, Pan ZK, Rodriguez A, Paterson Y. 2004. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine. Arch. Otolaryngol. Head Neck Surg. 130:92-97. (Pubitemid 38095437)
20. Sewell DA, Shahabi V, Gunn GR, 3rd, Pan ZK, Dominiecki ME, Paterson Y. 2004. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7. Cancer Res. 64:8821-8825. (Pubitemid 39665484)
21. Michel E, Reich KA, Favier R, Berche P, Cossart P. 1990. Attenuated mutants of the intracellular bacterium Listeria monocytogenes obtained by single amino acid substitutions in listeriolysin O. Mol. Microbiol. 4:2167-2178. (Pubitemid 120005277)
22. Lin KY, Guarnieri FG, Staveley-O'Carroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56:21-26. (Pubitemid 26010379)
23. Wood LM, Pan ZK, Shahabi V, Paterson Y. 2010. Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy. Cancer Immunol. Immunother. 59:1049-1058.
24. Cognet I, de Coignac AB, Magistrelli G, Jeannin P, Aubry JP, Maisnier-Patin K, Caron G, Chevalier S, Humbert F, Nguyen T, Beck A, Velin D, Delneste Y, Malissard M, Gauchat JF. 2003. Expression of recombinant proteins in a lipid A mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation. J. Immunol. Methods 272:199-210. (Pubitemid 36050756)
25. Glomski IJ, Gedde MM, Tsang AW, Swanson JA, Portnoy DA. 2002. The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells. J. Cell Biol. 156:1029-1038. (Pubitemid 34839852)
26. Park JM, Ng VH, Maeda S, Rest RF, Karin M. 2004. Anthrolysin O and other gram-positive cytolysins are Toll-like receptor 4 agonists. J. Exp. Med. 200:1647-1655. (Pubitemid 40094188)
27. Peng X, Hussain SF, Paterson Y. 2004. The ability of two Listeria monocytogenes vaccines targeting human papillomavirus-16 E7 to induce an antitumor response correlates with myeloid dendritic cell function. J. Immunol. 172:6030-6038. (Pubitemid 38621204)
28. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, Ferreira D, Smeaton S, El-Rachkidy R, McLoughlin RM, Mori A, Moran B, Fitzgerald KA, Tschopp J, Petrilli V, Andrew PW, Kadioglu A, Lavelle EC. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6:e1001191. doi:10.1371/journal.ppat.1001191.
29. Ray A, Biswas T. 2005. Porin of Shigella dysenteriae enhances Toll-like receptors 2 and 6 of mouse peritoneal B-2 cells and induces the expression of immunoglobulin M, immunoglobulin G2a and immunoglobulin A. Immunology 114:94-100. (Pubitemid 40030297)
30. Ito Y, Kawamura I, Kohda C, Tsuchiya K, Nomura T, Mitsuyama M. 2005. Seeligeriolysin O, a protein toxin of Listeria seeligeri, stimulates macrophage cytokine production via Toll-like receptors in a profile different from that induced by other bacterial ligands. Int. Immunol. 17:1597-1606. (Pubitemid 41754682)
31. Edelson BT, Unanue ER. 2002. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 169:3869-3875.
32. Barton GM, Medzhitov R. 2003. Toll-like receptor signaling pathways. Science 300:1524-1525. (Pubitemid 36682871)
33. Way SS, Thompson LJ, Lopes JE, Hajjar AM, Kollmann TR, Freitag NE, Wilson CB. 2004. Characterization of flagellin expression and its role in Listeria monocytogenes infection and immunity. Cell. Microbiol. 6:235-242. (Pubitemid 38248007)
34. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho T, Akira S, Reis e Sousa C. 2003. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33:827-833. (Pubitemid 36546669)
35. Means TK, Hayashi F, Smith KD, Aderem A, Luster AD. 2003. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J. Immunol. 170:5165-5175. (Pubitemid 36554749)
36. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto M, Takeuchi O, Itagaki S, Kumar N, Horii T, Akira S. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201:19-25. (Pubitemid 40130079)
37. Underhill DM, Gantner B. 2004. Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbes Infect. 6:1368-1373. (Pubitemid 41110579)